Therapeutic Asset Ratings

6,369 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Atezolizumab Ureter Transitional Cell Carcinoma	Alliance for Clinical Trials in Oncology	P3	B (62)
Atezolizumab Metastatic Renal Pelvis Urothelial Carcinoma	Alliance for Clinical Trials in Oncology	P3	B (62)
Atezolizumab Metastatic Ureter Urothelial Carcinoma	Alliance for Clinical Trials in Oncology	P3	B (62)
Atezolizumab Urothelial Carcinoma	LG Chem	P3	B (62)
Cetuximab Colon Carcinoma	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	P3	B (62)
Cetuximab Head And Neck Squamous Cell Carcinoma	Fate Therapeutics	P3	B (62)
Cetuximab Lung Cancer	Merck Sharp & Dohme LLC	P3	B (62)
Donanemab Brain Disorder	Eli Lilly and Company	P3	B (62)
Donanemab Dementia	Eli Lilly and Company	P3	B (62)
ibi310 Hepatocellular Carcinoma	Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.	P3	B (62)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Acute Myeloid Leukemia	Prelude Therapeutics	P3	B (62)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Hodgkins Lymphoma	Beijing Children's Hospital	P3	B (62)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER Non-Small Cell Lung Carcinoma	City of Hope Medical Center	P3	B (62)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER Melanoma	Fujian Cancer Hospital	P3	B (62)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER Non-Small Cell Lung Carcinoma	University of Chicago	P3	B (62)
Ipilimumab Nonpapillary Renal Cell Carcinoma	SWOG Cancer Research Network	P3	B (62)
Ipilimumab Liver Metastases	Vastra Gotaland Region	P3	B (62)
Ipilimumab Metastatic Malignant Neoplasm In The Brain	Stanford University	P3	B (62)
Ipilimumab Mucosal Melanoma	Melanoma Institute Australia	P3	B (62)
Ivonescimab Non-Small Cell Lung Carcinoma	European Organisation for Research and Treatment of Cancer - EORTC	P3	B (62)
Ivonescimab Triple-Negative Breast Carcinoma	Cedars-Sinai Medical Center	P3	B (62)
LECANEMAB Dementia	Washington University School of Medicine	P3	B (62)
MONOCLONAL ANTIBODY BC8 Acute Myeloid Leukemia	Actinium Pharmaceuticals	P3	B (62)
Nivolumab Cancer	Exelixis	P3	B (62)
Nivolumab Bone Metastases	National Cancer Institute (NCI)	P3	B (62)

Showing 701 to 725 of 6,369 assets

PreviousPage 29 of 255Next